Mitral valvulotomy has won particularly wide acceptance and, in selected, uncomplicated cases, has attained a favorably low operative mortality (5 per cent). Nevertheless, various problems that may ...
IT has been suggested 1,2 that severe pulmonary changes, supposedly irreversible, in patients with mitral stenosis would preclude beneficial results from valvulotomy. Recent publications from this ...
Cardiac Valvulotome Market is valued at US$ 108.8 Mn in 2023, and it is expected to reach US$ 152.0 Mn by 2031, with a CAGR of 4.4% during the forecast period of 2024-2031. InsightAce Analytic Pvt.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback